TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.080
-0.010 (-0.92%)
At close: Dec 5, 2025, 4:00 PM EST
1.090
+0.010 (0.94%)
After-hours: Dec 5, 2025, 7:55 PM EST
TScan Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 61 | 172 | 279 | 37 | 107 | - | |
| Market Cap Growth | -72.66% | -38.39% | 647.03% | -65.09% | - | - | |
| Enterprise Value | -28 | -9 | 150 | -66 | -69 | - | |
| Last Close Price | 1.08 | 3.04 | 5.83 | 1.55 | 4.50 | - | |
| PS Ratio | 7.28 | 61.00 | 13.25 | 2.76 | 10.54 | - | |
| PB Ratio | 0.43 | 0.71 | 1.85 | 0.38 | 0.67 | - | |
| P/TBV Ratio | 0.43 | 0.71 | 1.85 | 0.38 | 0.67 | - | |
| EV/Sales Ratio | - | - | 7.14 | - | - | - | |
| Debt / Equity Ratio | 0.66 | 0.40 | 0.61 | 0.87 | 0.04 | 0.43 | |
| Asset Turnover | 0.03 | 0.01 | 0.09 | 0.07 | 0.09 | 0.02 | |
| Quick Ratio | 6.32 | 8.07 | 6.44 | 6.94 | 7.56 | 1.99 | |
| Current Ratio | 6.44 | 8.14 | 6.51 | 7.17 | 7.76 | 2.09 | |
| Return on Equity (ROE) | -76.44% | -65.08% | -71.29% | -50.90% | -54.64% | -87.44% | |
| Return on Assets (ROA) | -30.45% | -26.20% | -24.79% | -21.51% | -25.56% | -33.08% | |
| Return on Capital (ROIC) | -33.24% | -28.97% | -27.25% | -23.65% | -31.75% | -45.49% | |
| Return on Capital Employed (ROCE) | -63.80% | -40.20% | -38.60% | -36.70% | -29.20% | -81.20% | |
| Earnings Yield | -232.67% | -74.22% | -32.00% | -177.43% | -45.48% | - | |
| FCF Yield | -221.66% | -66.74% | -23.14% | -189.50% | -54.82% | - | |
| Buyback Yield / Dilution | -6.36% | -18.32% | -98.89% | -106.20% | -1173.20% | -137.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.